Cellectis
CLLS
#7508
Rank
โ‚น37.02 B
Marketcap
โ‚น369.09
Share price
-15.24%
Change (1 day)
151.24%
Change (1 year)

Market capitalization of Cellectis (CLLS)

Market cap: โ‚น37.02 Billion

As of December 2025 Cellectis has a market cap of โ‚น37.02 Billion. This makes Cellectis the world's 7508th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cellectis from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น37.02 B200.08%
2024โ‚น12.33 B-32.77%
2023โ‚น18.35 B126.65%
2022โ‚น8.09 B-71.6%
2021โ‚น28.51 B-69.42%
2020โ‚น93.24 B75.32%
2019โ‚น53.18 B3.93%
2018โ‚น51.17 B-20.48%
2017โ‚น64.35 B56.41%
2016โ‚น41.14 B-42.34%
2015โ‚น71.36 B157.11%
2014โ‚น27.75 B570.96%
2013โ‚น4.13 B

End of Day market cap according to different sources

On Dec 16th, 2025 the market cap of Cellectis was reported to be:

โ‚น26.60 Billion
by Nasdaq info icon info icon
โ‚น37.02 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
uniQure
QURE
โ‚น123.95 B 234.76%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
โ‚น96.61 B 160.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น7.191 T 19,320.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚น41.72 B 12.67%๐Ÿ‡บ๐Ÿ‡ธ USA